[Federal Register Volume 83, Number 128 (Tuesday, July 3, 2018)]
[Notices]
[Pages 31159-31160]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-14317]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the National Advisory Neurological 
Disorders and Stroke Council.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable materials, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Neurological Disorders and 
Stroke Council.
    Date: September 12-13, 2018.
    Closed: September 12, 2018, 1:00 p.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, 31/6C, 
Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
    Closed: September 13, 2018, 8:00 a.m. to 10:00 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, 31/6C, 
Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
    Open: September 13, 2018, 10:00 a.m. to 3:30 p.m.
    Agenda: Report by the Director, NINDS; Report by the Director, 
Division of Extramural Activities; and Administrative and Program 
Developments.
    Place: National Institutes of Health, Building 31, 31/6C, 
Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Robert Finkelstein, Ph.D., Director, Division of 
Extramural Activities, National Institute of Neurological Disorders 
and Stroke, NIH, 6001 Executive Blvd., Suite 3309, MSC 9531, 
Bethesda, MD 20892, (301) 496-9248.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the

[[Page 31160]]

name, address, telephone number and when applicable, the business or 
professional affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance into Federal buildings. Visitors will be 
asked to show one form of identification (for example, a government-
issued photo ID, driver's license, or passport) and to state the 
purpose of their visit.
    Information is also available on the Institute's/Center's home 
page: http://www.ninds.nih.gov, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS).

    Dated: June 27, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-14317 Filed 7-2-18; 8:45 am]
BILLING CODE 4140-01-P